Literature DB >> 6631504

Management of carotid-cavernous fistulas by surgery combined with interventional radiology. Report of two cases.

B M Tress, K R Thomson, G L Klug, R R Mee, B Crawford.   

Abstract

Two cases of carotid-cavernous fistulas were successfully treated by standard interventional radiology techniques after otherwise inaccessible vessels were surgically exposed. In the first case, an internal carotid artery (ICA), which had previously been ligated as part of an attempted surgical "entrapment" procedure, was recanalized to permit passage of a detachable balloon catheter to the fistula, resulting in its obliteration. In the second case, an enlarged superior ophthalmic vein was exposed and isolated to facilitate retrograde catheterization of the cavernous sinus and obliteration of a dural fistula between the ICA and the cavernous sinus by steel Gianturco coils. The methods and complications of both procedures are discussed.

Entities:  

Mesh:

Year:  1983        PMID: 6631504     DOI: 10.3171/jns.1983.59.6.1076

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  3 in total

1.  Direct-puncture approach to the extraconal portion of the superior ophthalmic vein for carotid cavernous fistulae.

Authors:  A Kurata; S Suzuki; K Iwamoto; T Miyazaki; M Inukai; K Abe; J Niki; M Yamada; K Fujii; S Kan
Journal:  Neuroradiology       Date:  2009-07-04       Impact factor: 2.804

2.  Puncture of the superficial sylvian vein for embolisation of cavernous dural arteriovenous fistula.

Authors:  G Benndorf; T N Lehmann; H P Molsen; W Lanksch; R Felix
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

3.  Cavernous sinus dural fistulae treated by transvenous approach through the facial vein: report of seven cases and review of the literature.

Authors:  Alessandra Biondi; Dan Milea; Christophe Cognard; Giuseppe K Ricciardi; Fabrice Bonneville; Rémy van Effenterre
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.